newsfilter
← Latest News
GlobeNewswire·

NRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine

WILMINGTON, Del., Oct. 29, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP, "NRx" or "the Company")), a clinical-stage biopharmaceutical company developing therapeutics based on its